Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MIMEDX GROUP, INC. | Chief Executive Officer, Director | Common Stock | 1.71M | $12.2M | $7.16 | Jun 9, 2022 | Direct |
Protagenic Therapeutics, Inc.\new | Director | PTIX Common stock Options | 21.3K | $37K | $1.74 | Mar 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PTIX | Protagenic Therapeutics, Inc.\new | Mar 25, 2024 | 1 | $37K | 4 | Apr 1, 2024 | Director |
MDXG | MIMEDX GROUP, INC. | Jun 9, 2022 | 1 | -$420K | 4 | Jun 13, 2022 | Chief Executive Officer, Director |
MDXG | MIMEDX GROUP, INC. | Apr 8, 2022 | 1 | $2.78M | 4 | Apr 12, 2022 | Chief Executive Officer, Director |
MDXG | MIMEDX GROUP, INC. | Mar 8, 2022 | 1 | -$222K | 4 | Mar 10, 2022 | Chief Executive Officer, Director |
MDXG | MIMEDX GROUP, INC. | Feb 23, 2022 | 1 | -$263K | 4 | Feb 25, 2022 | Chief Executive Officer, Director |
MDXG | MIMEDX GROUP, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Chief Executive Officer, Director |